Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 2/20 | 0.39 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CCR5 | P51681 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31228306 | 0.95 | MMP13 (0.40) | MMP13HCRTR2KMT2AMEN1P2RX7 | |
| SCHEMBL31228300 | 0.95 | MMP13 (0.40) | MMP13HCRTR2KMT2AMEN1P2RX7 | |
| SCHEMBL31228427 | 0.90 | MMP13 (0.37) | MMP13KMT2AMEN1P2RX7CCR5 | |
| SCHEMBL31228488 | 0.89 | P2RX7 (0.41) | HCRTR2KMT2AMEN1P2RX7MAPT | |
| SCHEMBL31228367 | 0.88 | MMP13 (0.40) | MMP13HCRTR2KMT2AMEN1P2RX7 | |
| SCHEMBL31228678 | 0.87 | MMP13 (0.37) | MMP13HCRTR2KMT2AMEN1NPSR1 | |
| SCHEMBL31228374 | 0.84 | P2RX7 (0.42) | KMT2AMEN1NPSR1P2RX7MAPT | |
| SCHEMBL31153630 | 0.83 | MMP13 (0.40) | MMP13KMT2AMEN1P2RX7CCR5 | |
| SCHEMBL31228376 | 0.82 | MMP13 (0.38) | MMP13HCRTR2KMT2AMEN1NPSR1 | |
| SCHEMBL31228389 | 0.81 | MMP13 (0.40) | MMP13KMT2AMEN1P2RX7GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688789-A1 | MACROCYCLIC RAS INHIBITORS | Revolution Medicines, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024211663-A9 | MACROCYCLIC RAS INHIBITORS | Revolution Medicines, Inc. (US) | 2025-01-30 | — | — | WO | disclosed |
| WO-2024211663-A1 | CONDENSED MACROCYCLIC COMPOUNDS AS RAS INHIBITORS | Revolution Medicines, Inc. (US) | 2024-10-10 | — | — | WO | disclosed |